Eduardo Hidalgo releases a memoir through Autsaider Cómics detailing nearly forty years of heroin use. A guilt-free testimony that challenges the only narrative society accepts about this substance.

In a cross-sectional survey of 497 people with MDMA experience, 74.5% reported negative aftereffects at least once. This self-reported sample does not establish causality, represent all users or demonstrate that supplements or antidepressants are effective for managing comedowns.

A guide to distinguishing LSD from 25i-NBOMe: key identifiers and harm reduction tips to avoid dangerous mix-ups.

We critically examine clinical trials of psilocybin and LSD in terminal illness: modest outcomes contrasting with euphoric media headlines.

A critical analysis of how public health harm reduction strategies face sensationalist headlines, statistical ignorance, and polarization.

We explore the clinical profile of ketamine, from its safety in surgery to its emerging role in treatment-resistant depression and addiction.

We explore evidence for the analgesic properties of MDMA, analyzing its serotonergic mechanism, historical clinical cases, and harm reduction.